Tower Research Capital LLC (Trc) Axogen, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Axogen, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,298 shares of AXGN stock, worth $44,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,298
Previous 3,385
32.11%
Holding current value
$44,650
Previous $47,000
21.28%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$87.6 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$63.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$57.4 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$47.1 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $822M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...